Deep Brain Stimulation Devices Companies, Corporate Milestones

Top Companies and Their Offerings

What are the Recent Developments in the Market?

• In March 2026, Adaptive Deep Brain Stimulation (aDBS), sensing real-time brain signals related to Parkinson’s symptoms and automatically adjusting stimulation levels throughout the day and night, was launched by Aster Medcity at its Parkinson and Movement Disorders centre
• In October 2025, the world's first closed-loop DBS system for Parkinson's patients, that is, BrainSense™ Adaptive Deep Brain Stimulation (aDBS), developed by Medtronic plc., was recognized in the annual list of Best Inventions by TIME.

Market Value Chain Analysis

R&D

• The R&D of the deep brain stimulation devices focuses on the development of closed-loop adaptive stimulation and sensing technology.
• Key players: Medtronic plc., Boston Scientific, and Abbott Laboratories.

Clinical Trials and Regulatory Approvals

• The safety, battery longevity, and stimulation precision are evaluated in the clinical trials and regulatory approvals of the deep-brain stimulation devices.
• Key players: Medtronic plc., Boston Scientific, and Abbott Laboratories.

Packaging and Serialization

• The packing and serialization of the deep brain stimulation devices involves the use of high-barrier, sterile Tyvek pouching, medical-grade trays, and GS1-compliant unique device identification.
• Key players: Medtronic plc., Boston Scientific, and Abbott Laboratories.

Distribution to Hospitals, Pharmacies

• The specialized direct-to-hospital supply chains and third-party logistics providers are responsible for the distribution of the deep-brain stimulation devices to the hospitals and pharmacies.
• Key players: Medtronic plc., Boston Scientific, and Abbott Laboratories.

Patient Support and Services

• The remote programming platforms, digital apps, and 24/7 technical helplines are provided in the patent support and services of the deep brain stimulation devices.
• Key players: Medtronic plc., Boston Scientific, and Abbott Laboratories.

Market Growth

The global deep brain stimulation devices market size was estimated at USD 2.15 billion in 2025 and is predicted to increase from USD 2.34 billion in 2026 to approximately USD 5.04 billion by 2035, expanding at a CAGR of 8.9% from 2026 to 2035.